Product logins

Find logins to all Clarivate products below.


Diabetes Care Devices – Market Insights – Europe (Supplemental)

The COVID-19 pandemic has had a negative impact on the growth of the European diabetes care device market in the short term. However, the market is projected to be driven by the introduction of new technologies, trends such as remote patient monitoring, and the adoption of innovative products like hybrid closed-loop insulin pumps and patch pumps. These advanced products are anticipated to command higher prices and contribute to moderate growth over the forecast period.

This Medtech 360 Report provides high-level market metrics for Diabetes care Devices in Europe, including country-level data for major countries and aggregate data for the rest of the supplemental countries from 2019 through 2032.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Interventional Oncology Devices – Market Insights – Latin America
The Latin American interventional oncology device market will see moderate growth through 2034, driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of…
Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…
Report
Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific diabetes care device market is expected to experience moderate growth over the forecast period, driven by a rising diabetes population, untapped market opportunities, regulatory…
Report
Pain Management Devices – Market Insights – United States
The US pain management device market is driven by continuous product innovation aimed at enhancing treatment efficacy and addressing new indications. Favorable clinical evidence and pain management…